Deutsche Bank’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$508K Buy
33,938
+5,455
+19% +$81.7K ﹤0.01% 2443
2025
Q1
$460K Sell
28,483
-2,935
-9% -$47.4K ﹤0.01% 2510
2024
Q4
$731K Buy
31,418
+9,910
+46% +$231K ﹤0.01% 2385
2024
Q3
$633K Buy
21,508
+5,263
+32% +$155K ﹤0.01% 2295
2024
Q2
$382K Buy
16,245
+15,947
+5,351% +$375K ﹤0.01% 2437
2024
Q1
$11.3K Buy
+298
New +$11.3K ﹤0.01% 3462
2022
Q2
Sell
-20,605
Closed -$1.19M 4120
2022
Q1
$1.19M Buy
20,605
+19,624
+2,000% +$1.13M ﹤0.01% 2233
2021
Q4
$117K Buy
981
+51
+5% +$6.08K ﹤0.01% 3586
2021
Q3
$185K Sell
930
-30
-3% -$5.97K ﹤0.01% 3570
2021
Q2
$167K Sell
960
-269
-22% -$46.8K ﹤0.01% 3835
2021
Q1
$243K Sell
1,229
-110
-8% -$21.7K ﹤0.01% 3506
2020
Q4
$263K Sell
1,339
-1,283
-49% -$252K ﹤0.01% 3277
2020
Q3
$465K Buy
2,622
+81
+3% +$14.4K ﹤0.01% 2655
2020
Q2
$588K Buy
2,541
+501
+25% +$116K ﹤0.01% 2524
2020
Q1
$238K Sell
2,040
-511
-20% -$59.6K ﹤0.01% 2840
2019
Q4
$486K Buy
2,551
+2,269
+805% +$432K ﹤0.01% 2717
2019
Q3
$53K Sell
282
-396
-58% -$74.4K ﹤0.01% 3791
2019
Q2
$115K Sell
678
-236
-26% -$40K ﹤0.01% 4014
2019
Q1
$183K Buy
914
+146
+19% +$29.2K ﹤0.01% 3955
2018
Q4
$143K Sell
768
-721
-48% -$134K ﹤0.01% 3925
2018
Q3
$356K Sell
1,489
-5,931
-80% -$1.42M ﹤0.01% 3894
2018
Q2
$1.96M Buy
+7,420
New +$1.96M ﹤0.01% 2956
2017
Q3
Sell
-20
Closed -$1K 4490
2017
Q2
$1K Sell
20
-178
-90% -$8.9K ﹤0.01% 4413
2017
Q1
$36K Buy
+198
New +$36K ﹤0.01% 4034
2016
Q3
Sell
-37
Closed -$4K 4651
2016
Q2
$4K Buy
+37
New +$4K ﹤0.01% 4631